🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsSemaglutide (Ozempic / Wegovy)Month 2 and I have lost NOTHING - normal?? — looking for input Page 4

Month 2 and I have lost NOTHING - normal?? — looking for input

roxy_nash Wed, Feb 7, 2024 at 7:52 PM 37 replies 2,431 viewsPage 4 of 8
newstart_MO
New Member
12
45
Feb 2026
Springfield, MO
Feb 12, 2024 at 2:36 PM#16

Clinical perspective, offered as context rather than as advice. The honest answer is that the effect is real, the magnitude is contested, and the individual variation is larger than either. Those three things can all be true at once, and most arguments here are two people holding different parts of that.

Happy to go further on any of that.

49 22bri_stats, pete_manc_UK, anna.melb_AU and 46 others
Reply Quote Save Share Report
NicoleRaleigh
Member
356
1,567
Aug 2024
Raleigh, NC
Feb 12, 2024 at 5:26 PM#17
newstart_MO said:
The honest answer is that the effect is real, the magnitude is contested, and the individual variation is larger than either.

This matches mine closely enough to be worth saying so out loud.

Last edited: Feb 12, 2024 at 6:26 PM
50 23MikeFit_NJ, InsuranceTom, WendyG_ATL and 47 others
Reply Quote Save Share Report
Dr.SurgeonPGH
Senior Member
1,345
6,789
Mar 2024
Pittsburgh, PA
Feb 12, 2024 at 8:16 PM#18
newstart_MO said:
The honest answer is that the effect is real, the magnitude is contested, and the individual variation is larger than either.

Adding the part of the answer the thread has not reached. The dose-response is real but shallow at the top. Across STEP 1 and STEP 4 the gap between 1.7mg and 2.4mg is a couple of percentage points of body weight on average, and the average is carrying a wide spread — plenty of people at 1.7mg sit above the 2.4mg mean. If a dose is working and tolerable, "working" is the relevant variable, not "maximal".

1 24PharmHunterJen
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
bri_stats
Member
789
3,456
May 2024
Seattle, WA
Feb 12, 2024 at 11:06 PM#19

One concrete data point for the thread. If you are comparing against somebody else’s result, check that you are comparing the same measurement taken the same way. Most of the apparent contradictions in these threads dissolve at that step.

2 0JessicaM_2024, TomFromTexas
Reply Quote Save Share Report
mike_mod
Moderator
7,234
19,823
Nov 2023
New York
Online
Feb 13, 2024 at 1:56 AM#20

Moderator note: the sourcing question belongs in the vendor section and has been split out.

24 22PurityPaulOR, MaxMetOK, MounjBrad and 21 others
Reply Quote Save Share Report

Similar Threads

STEP 1-5 trials comprehensive summary — efficacy endpoints compiled12 replies
Oral semaglutide 50mg Phase 3 — OASIS program results16 replies
Semaglutide pharmacokinetics — half-life, Tmax, steady state modeling10 replies
Compounded semaglutide stability data — temperature and light sensitivity16 replies
0.25mg → 2.4mg titration: optimal schedule based on clinical data6 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register